CA health dept. launches Open Data Portal

Laura Pedulli | | Health Exec | Economics

The California Department of Public Health (CDPH) has launched an Open Data Portal to provide user-friendly access to publicly available information for researchers, clinicians, developers and the public.

The concept of “Open Data” describes data that are freely available, machine-readable and formatted according to national technical standards to facilitate visibility and reuse of published data. CDPH is releasing aggregated data meeting four “open” criteria, including public accessibility, availability on multiple formats, free of charge and unlimited use and distribution rights, according to the agency.

Data on the site are diverse, and they include poverty rates, birth and death profiles, West Nile virus prevalence, ER asthma hospitalizations by zip code and age, and locations of healthcare facilities.

“We are committed to increasing public access to one of the State’s most valuable assets—non-confidential health and human services data while also ensuring privacy and confidentiality,” explained CDPH on the web site.

Visit the portal here.

 

 

Laura Pedulli

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.